. we have let patients down, admits senior northern ireland civil servant .
elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital..
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
.